Richard David Abbott - 23 Nov 2024 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Role
President
Signature
Richard David Abbott
Issuer symbol
CODX
Transactions as of
23 Nov 2024
Transactions value $
-$6,146
Form type
4
Filing time
25 Nov 2024, 16:02:38 UTC
Previous filing
29 Apr 2024
Next filing
27 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CODX Common Stock Award $0 +20,000 $0 20,000 23 Nov 2024 Direct F1
transaction CODX Common Stock Disposed to Issuer -$6,145 -6,085 -30.42% $1.01 13,915 23 Nov 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CODX Restricted Stock Unit Options Exercise $0 -20,000 -11.73% $0 150,438 23 Nov 2024 Common Stock 170,438 $0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Included in 120,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2024.
F2 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.